Orai1-Mediated ICRAC Is Essential for Neointima Formation After Vascular InjuryNovelty and Significance by Wei Zhang, Katharine E. Halligan, Xuexin Zhang,

Slides:



Advertisements
Similar presentations
Fig. 1 Expression levels of DNA damage repair genes RAD51 and BRCA1 in fibroids (F) and adjacent myometrial tissues (MyoF) as well as primary cells. Each.
Advertisements

Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs  Huey-Ming Lo, Min-Wen Wu, Shiow-Lin.
Alpha-lipoic acid inhibits fractalkine expression and prevents neointimal hyperplasia after balloon injury in rat carotid artery  Kyeong-Min Lee, Keun-Gyu.
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Role of Jagged1 in Arterial Lesions After Vascular Injury
by Johannes B. K. Schwarz, Nicolas Langwieser, Nicole N
Hypoxia-Inducible Factor-1α Mediates Increased Sympathoexcitation via Glutamatergic N-Methyl-d-Aspartate Receptors in the Paraventricular Nucleus of Rats.
by Javier Navarro-Antolín, Konstantin L
Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway SuppressionCLINICAL PERSPECTIVE by Daile.
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Role of RBM25/LUC7L3 in Abnormal Cardiac Sodium Channel Splicing Regulation in Human Heart FailureClinical Perspective by Ge Gao, An Xie, Shu-Ching Huang,
Dapper-1 Induces Myocardial Remodeling Through Activation of Canonical Wnt Signaling in CardiomyocytesNovelty and Significance by Marco Hagenmueller, Johannes.
Role for Hyaluronan Synthase 3 in the Response to Vascular Injury
by Yanping Liu, Ken Terata, Nancy J. Rusch, and David D. Gutterman
Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide  Yue Li, Lucinda.
Volume 15, Issue 6, Pages (June 2009)
Mira Park, Ph. D. , Dae-Shik Suh, M. D. , Kangseok Lee, Ph. D
Volume 78, Issue 3, Pages (August 2010)
Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats 
Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial.
ORAI1 Ca2+ Channels Control Endothelin-1-Induced Mitogenesis and Melanogenesis in Primary Human Melanocytes  Hedwig Stanisz, Alexandra Stark, Tatiana.
Volume 81, Issue 1, Pages (January 2012)
Volume 20, Issue 5, Pages (May 2011)
Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expression  Gaofeng Zhao, MD, PhD,
Volume 137, Issue 2, Pages e2 (August 2009)
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature  Nick D. Tsihlis, PhD, Muneera R.
Volume 88, Issue 4, Pages (October 2015)
VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery  Yanming Qu, MD, Xiangen Shi, MD, Hongwei Zhang,
VEGF Gene Delivery to Muscle
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice  Daniël Eefting,
Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms  Milton Hamblin, PhD, Lin Chang,
TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow by Shoichiro Tsuji, Catarina Cortesão,
Chakradhari Sharan, Ph. D. , Sunil K. Halder, Ph. D
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Lysophosphatidic Acid Promotes Cell Migration through STIM1- and Orai1-Mediated Ca2+i Mobilization and NFAT2 Activation  Ralph Jans, Laura Mottram, Darren.
Volume 11, Issue 6, Pages (June 2012)
Adenovirus-mediated intra-arterial delivery of cellular repressor of E1A-stimulated genes inhibits neointima formation in rabbits after balloon injury 
Volume 12, Issue 3, Pages (July 2015)
Knockdown of Myosin Va Isoforms by RNAi as a Tool to Block Melanosome Transport in Primary Human Melanocytes  Mireille Van Gele, Barbara Geusens, Anne-Marie.
International Journal of Cardiology
Stefan W. Stoll, Jessica L. Johnson, Yong Li, Laure Rittié, James T
Volume 69, Issue 2, Pages (August 2018)
S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo  Yih-Jer Wu, MD, PhD, Graciela.
Peroxisome Proliferator-Activated Receptor-α Is a Functional Target of p63 in Adult Human Keratinocytes  Silvia Pozzi, Michael Boergesen, Satrajit Sinha,
Volume 11, Issue 4, Pages (October 2018)
Nick D. Tsihlis, PhD, Jozef Murar, BA, Muneera R. Kapadia, MD, Sadaf S
Volume 8, Pages (October 2018)
Marcel Scheinman, MD, Enrico Ascher, MD, Gabriel S
Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury  Michael C Moon, MD, Katerina Molnar,
Knockdown of DAO inhibits DNA damage–induced senescence.
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin- induced acute kidney injury  K. Negishi, E. Noiri, R. Maeda, D.
Pituitary Tumor-Transforming Gene 1 Enhances Proliferation and Suppresses Early Differentiation of Keratinocytes  Yosuke Ishitsuka, Yasuhiro Kawachi,
Volume 23, Issue 2, Pages (April 2018)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
Insulin-Like Growth Factor-Binding Protein 7 Regulates Keratinocyte Proliferation, Differentiation and Apoptosis  Janna Nousbeck, Ofer Sarig, Nili Avidan,
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Yehuda G. Wolf, MD, Lars M. Rasmussen, MD, Yoav Sherman, MD, Warner P
STIM2 Is an Inhibitor of STIM1-Mediated Store-Operated Ca2+ Entry
Volume 26, Issue 1, Pages (July 2014)
Merkel Cell Polyomavirus–Positive Merkel Cell Carcinoma Cells Do Not Require Expression of the Viral Small T Antigen  Sabrina Angermeyer, Sonja Hesbacher,
eIF5A-PEAK1 signaling regulates KRAS protein expression.
Nick D. Tsihlis, PhD, Jozef Murar, BA, Muneera R. Kapadia, MD, Sadaf S
Downregulation of caveolin-1 by si-RNA in NIH3T3 cells increased survivin expression. Downregulation of caveolin-1 by si-RNA in NIH3T3 cells increased.
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts  Hiroshi Banno, MD, Yoshifumi Takei, PhD,
Artificial Zinc-Finger Transcription Factor of A20 Suppresses Restenosis in Sprague Dawley Rats after Carotid Injury via the PPARα Pathway  Zhaoyou Meng,
Effect of G9a on the expression of GSH synthesis enzymes.
Volume 3, Issue 1, Pages 8-13 (January 2001)
Fig. 5 C9orf72 knockdown disrupts autophagy induction.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
Presentation transcript:

Orai1-Mediated ICRAC Is Essential for Neointima Formation After Vascular InjuryNovelty and Significance by Wei Zhang, Katharine E. Halligan, Xuexin Zhang, Jonathan M. Bisaillon, José C. Gonzalez-Cobos, Rajender K. Motiani, Guoqing Hu, Peter A. Vincent, Jiliang Zhou, Margarida Barroso, Harold A. Singer, Khalid Matrougui, and Mohamed Trebak Circulation Research Volume 109(5):534-542 August 19, 2011 Copyright © American Heart Association, Inc. All rights reserved.

Effect of shOrai1 and shSTIM1 lentiviruses on store-operated Ca2+ entry (SOCE) and ICRAC. A, Cultured vascular smooth muscle cells (VSMCs) were infected with either shLuciferase, shOrai1 or shSTIM1 lentiviruses and infected cells are visualized by green fluorescent protein (GFP) fluorescence. Effect of shOrai1 and shSTIM1 lentiviruses on store-operated Ca2+ entry (SOCE) and ICRAC. A, Cultured vascular smooth muscle cells (VSMCs) were infected with either shLuciferase, shOrai1 or shSTIM1 lentiviruses and infected cells are visualized by green fluorescent protein (GFP) fluorescence. Phase pictures are shown to gauge the infection efficiency. Note the reduced cell number in shOrai1 and shSTIM1 conditions compared to shLuciferase control. B, Quantitative PCR shows that shOrai1 and shSTIM1 lentiviruses specifically and efficiently reduced their target mRNA (normalized to rpl32 mRNA) 5 days postinfection. ShOrai1and shSTIM1 infection of VSMCs caused a small (not statistically significant) increase in STIM1 and Orai1 mRNA, respectively. C, Western blotting shows that shOrai1 and shSTIM1 lentiviruses caused efficient protein knockdown of their respective proteins 5 days postinfection. D, Statistical analysis of Orai1 and STIM1 band densitometry normalized to β-actin is shown. E, The shOrai1 lentiviral infection essentially abrogated SOCE activated by thapsigargin (2 μmol/L) in comparison with shLuciferase lentivirus control in VSMCs; statistical analysis from 3 independent experiments totaling 21 cells is depicted (control shluciferase, 3 experiments, n=23). F, The shSTIM1 lentiviral infection also caused substantial reduction in SOCE activated by thapsigargin (2 μmol/L) in comparison with shLuciferase lentivirus control in VSMCs; statistical analysis from 3 independent experiments totaling 19 cells is depicted (control shluciferase, 3 experiments, n=24). G through I, Whole cell patch clamp recordings of ICRAC activated in VSMCs by dialysis of 20 mmol/L BAPTA through the patch pipette and showing substantial decrease of Ca2+ ICRAC currents (at −100 mV) recorded in 20 mmol/L external Ca2+ and Na+ ICRAC currents recorded in divalent free (DVF) external solutions, from shOrai1− (n=4) and shSTIM1-infected VSMCs (n=5) in comparison with shLuciferase-infected VSMCs (n=3). A DVF pulse was applied immediately after break-in to gauge leak current, which was subsequently subtracted from the DVF current obtained after store depletion. J, I/V relationships of Na+ ICRAC from VSMCs infected with shLuciferase, shOrai1, or shSTIM1 lentiviruses were taken where indicated by the color-coded asterisks. K, Statistical analyses on Ca2+ ICRAC and Na+ ICRAC currents taken at −100 mV from several independent VSMCs infected with shLuciferase, shOrai1, or shSTIM1 lentiviruses. Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.

Orai1/STIM1 proteins and balloon carotid injury in rats. Orai1/STIM1 proteins and balloon carotid injury in rats. A, H&E staining of balloon-injured left carotid artery sections showing increased neointima as early as 7 days after injury in comparison with sham-operated arteries (intact). Neointima formation peaks at 14 days postinjury and is still prominent 21 days postinjury. B, IF staining with specific antibodies shows increased protein expression of Orai1 and STIM1in neointima of left injured carotid arteries 7 days postinjury in comparison with right noninjured control carotids. IF staining also shows increased expression of the proliferative marker Ki67 and decreased expression of vascular smooth muscle cell (VSMC) contractile marker myosin heavy chain (MHC) in neointimal layers of balloon-injured left carotid artery sections in comparison withright noninjured control carotids. C, Western blotting on medial and neointimal VSMC from balloon-injured left carotid arteries in comparison withthe medial layer from sham-operated arteries showing increased protein expression of Orai1, STIM1, and the proliferative marker proliferating cell nuclear antigen (PCNA) in balloon-injured left carotid arteries 14 days postinjury. A = adventitia; M = media; NI = neointima; L = leumen. Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.

Orai1/STIM1 ShRNA lentiviral infection, vascular smooth muscle cell (VSMC) proliferation, and protein expression. Orai1/STIM1 ShRNA lentiviral infection, vascular smooth muscle cell (VSMC) proliferation, and protein expression. A, ShLuciferase, shOrai1, and shSTIM1 lentiviruses efficiently infected carotid vessels as evidenced with expression of green fluorescent protein (GFP) in medial and neointimal protein extracts from left carotid arteries that are balloon injured (14 days after injury) and infected with viral particles; right noninfected carotids show no GFP expression. ShOrai1 inhibited upregulation of Orai1 protein as well as that of STIM1 and CamKIIδ2, 14 days postinjury. Similarly, shSTIM1 inhibited upregulation of STIM1 protein as well as that of Orai1 and CamKIIδ2. ShOrai1 and shSTIM1 inhibited VSMC proliferation as evidenced by reduced protein expression of proliferating cell nuclear antigen (PCNA) in medial and neointimal protein extracts from balloon-injured left carotids treated with shOrai1 and shSTIM1 lentiviruses in comparison withinjured left carotids treated with shLuciferase lentiviruses. B, Statistical analyses on Orai1, STIM1, CamKIIδ2, and PCNA protein expression data on extracts of medial and neointimal VSMC from ballon-injured left carotids and treated with shLuciferase, shOrai1, or shSTIM1 lentiviruses. Data represent densitometry on protein bands with average ±SEM from 6 rats per condition, determined using Image J and normalized to βactin expression. C through D, IF using specific anti-Orai1 (C) and anti-STIM1 (D) antibodies on left carotid sections (14 days after injury) injured and treated with shLuciferase, shOrai1, or shSTIM1 lentiviruses (bottom) and corresponding right noninjured nontreated control carotids (top). Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.

ShOrai1 and shSTIM1 lentiviral infection after balloon-injury inhibited neointima formation. ShOrai1 and shSTIM1 lentiviral infection after balloon-injury inhibited neointima formation. A, H&E staining on left carotid artery sections from either sham-operated (intact) or balloon-injured rats treated with shLuciferase (shLuc), shOrai1, or shSTIM1 lentiviruses 14 days postinjury and lentiviral treatment. B and C, Statistical analyses on medial and neointimal areas (mm2; B) and media/neointima (M/N) ratios (C) from 5 to 7 independent rats per condition determined using the Image J software from left injured and treated with lentiviruses and right noninjured nontreated controls. Neointimal regions are highlighted in green. Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.

Orai1 and STIM1 knockdown prevents nuclear factor for activated T cells (NFAT) nuclear translocation and activity. Orai1 and STIM1 knockdown prevents nuclear factor for activated T cells (NFAT) nuclear translocation and activity. A, Vascular smooth muscle cell (VSMCs) were transfected with a plasmid encoding NFAT- green fluorescent protein (GFP) after transfection with either siRNA against Orai1 (siO1), STIM1 (siS1), or nontargeting siRNA control (siNT). NFAT-GFP nuclear translocation in response to thapsigargin (2 μmol/L for 15 minutes) was monitored under fluorescence microscope. B, Data were quantified using Image J, and efficiency of NFAT-GFP translocation was represented as a ratio of GFP fluorescence in nucleus/cytosol. C, Luciferase reporter assays with and without 2 μmol/L thapsigargin treatment of VSMCs transfected with siOrai1 (siO1), siSTIM1 (siS1), or nontargeting siRNA (siNT). Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.

Orai1/STIM1 proteins are upregulated in carotid arteries from mice subjected to ligation. Orai1/STIM1 proteins are upregulated in carotid arteries from mice subjected to ligation. IHC staining with specific antibodies against Orai1 and STIM1 in ligation-injured carotids from mice shows a marked upregulation of Orai1 and STIM1 proteins in media and neointima from ligation-injured carotids 21 days postligation in comparison with their respective control vessels. Contiguous sections from the same vessels were also stained with anti-SMα-actin antibody as a vascular smooth muscle cell (VSMC) marker. Dilutions used for primary antibodies are anti-Orai1, 1:400; anti-STIM1, 1:2000 (inset section dilution was 1:1200 for control vessel); anti-SMα-actin, 1:800. Wei Zhang et al. Circ Res. 2011;109:534-542 Copyright © American Heart Association, Inc. All rights reserved.